Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Confirmation of the drug-drug interaction potential between cobicistat-boosted antiretroviral regimens and hormonal contraceptives.

Majeed SR, West S, Ling KH, Das M, Kearney BP.

Antivir Ther. 2020 Jan 14. doi: 10.3851/IMP3343. [Epub ahead of print]

PMID:
31933482
2.

Filgotinib, a JAK1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects.

Anderson K, Xin Y, Zheng H, Yun C, Kwan E, Qin A, Namour F, Kearney BP, Mathias A.

Clin Pharmacol Drug Dev. 2019 Dec 2. doi: 10.1002/cpdd.755. [Epub ahead of print]

PMID:
31797578
3.

The determination of human peripheral blood mononuclear cell counts using a genomic DNA standard and application in tenofovir diphosphate quantitation.

Xiao D, Ling KHJ, Tarnowski T, Majeed SR, Kearney B, Kolaris C, Zondlo S.

Anal Biochem. 2019 Nov 15;585:113399. doi: 10.1016/j.ab.2019.113399. Epub 2019 Aug 19.

PMID:
31437427
4.

DRoP: Automated detection of conserved solvent-binding sites on proteins.

Kearney BM, Schwabe M, Marcus KC, Roberts DM, Dechene M, Swartz P, Mattos C.

Proteins. 2020 Jan;88(1):152-165. doi: 10.1002/prot.25781. Epub 2019 Jul 23.

PMID:
31294888
5.

Improving Access to High-Cost Technologies in the Asia Region.

Mundy L, Trowman R, Kearney B.

Int J Technol Assess Health Care. 2019 Jan;35(3):168-175. doi: 10.1017/S026646231900031X. Epub 2019 May 24.

PMID:
31122302
6.

Predicted heart mass is the optimal metric for size match in heart transplantation.

Kransdorf EP, Kittleson MM, Benck LR, Patel JK, Chung JS, Esmailian F, Kearney BL, Chang DH, Ramzy D, Czer LSC, Kobashigawa JA.

J Heart Lung Transplant. 2019 Feb;38(2):156-165. doi: 10.1016/j.healun.2018.09.017. Epub 2018 Sep 27.

PMID:
30528987
7.

Is serum ferritin a reliable indicator of iron status in elective major surgery patients?

Kearney BJ, To LB.

Intern Med J. 2018 Nov;48(11):1413. doi: 10.1111/imj.14091. No abstract available.

PMID:
30387304
8.

OVERCOMING THE BARRIERS TO ACHIEVING UNIVERSAL HEALTH CARE IN THE ASIAN REGION.

Mundy L, Trowman R, Kearney B.

Int J Technol Assess Health Care. 2018 Jan;34(4):352-359. doi: 10.1017/S0266462318000417. Epub 2018 Jul 10.

PMID:
29986782
9.

Assessment of vestibular function in patients with chronic middle ear disease using the VHIT and VEMP test.

Sandhu JS, Yung M, Parker-George J, Kearney B, Ray J.

Clin Otolaryngol. 2018 Apr 17. doi: 10.1111/coa.13118. [Epub ahead of print] No abstract available.

PMID:
29665318
10.

Pharmacokinetics of Tenofovir Alafenamide When Coadministered With Other HIV Antiretrovirals.

Begley R, Das M, Zhong L, Ling J, Kearney BP, Custodio JM.

J Acquir Immune Defic Syndr. 2018 Aug 1;78(4):465-472. doi: 10.1097/QAI.0000000000001699.

PMID:
29649076
11.

Drug-Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/Sofosbuvir.

German P, Mathias A, Brainard DM, Kearney BP.

Clin Pharmacokinet. 2018 Nov;57(11):1369-1383. doi: 10.1007/s40262-018-0654-5. Review.

PMID:
29644537
12.

Cytochrome P450 3A Induction Predicts P-glycoprotein Induction; Part 1: Establishing Induction Relationships Using Ascending Dose Rifampin.

Lutz JD, Kirby BJ, Wang L, Song Q, Ling J, Massetto B, Worth A, Kearney BP, Mathias A.

Clin Pharmacol Ther. 2018 Dec;104(6):1182-1190. doi: 10.1002/cpt.1073. Epub 2018 Apr 19.

13.

Cytochrome P450 3A Induction Predicts P-glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine.

Lutz JD, Kirby BJ, Wang L, Song Q, Ling J, Massetto B, Worth A, Kearney BP, Mathias A.

Clin Pharmacol Ther. 2018 Dec;104(6):1191-1198. doi: 10.1002/cpt.1072. Epub 2018 Apr 26.

14.

From amorphous to nanocrystalline: the effect of nanograins in an amorphous matrix on the thermal conductivity of hot-wire chemical-vapor deposited silicon films.

Kearney BT, Jugdersuren B, Queen DR, Metcalf TH, Culbertson JC, Desario PA, Stroud RM, Nemeth W, Wang Q, Liu X.

J Phys Condens Matter. 2018 Feb 28;30(8):085301. doi: 10.1088/1361-648X/aaa43f.

PMID:
29283107
15.

Sequence Optimized Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of Crimean-Congo Hemorrhagic Fever Virus.

Koehler JW, Delp KL, Hall AT, Olschner SP, Kearney BJ, Garrison AR, Altamura LA, Rossi CA, Minogue TD.

Am J Trop Med Hyg. 2018 Jan;98(1):211-215. doi: 10.4269/ajtmh.17-0165.

16.

A Thorough QT Study to Evaluate the Effects of Supratherapeutic Doses of Ledipasvir on the QTc Interval in Healthy Subjects.

German P, Mathias A, Brainard DM, Song Q, Ling J, Kearney BP.

Clin Pharmacol Drug Dev. 2018 Aug;7(6):641-651. doi: 10.1002/cpdd.390. Epub 2017 Oct 23.

PMID:
29058821
17.

Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide.

Custodio JM, Chuck SK, Chu H, Cao H, Ma G, Flaherty J, Ling J, Kearney BP.

Pharmacol Res Perspect. 2017 Oct;5(5). doi: 10.1002/prp2.353.

18.

Accurate virus quantitation using a Scanning Transmission Electron Microscopy (STEM) detector in a scanning electron microscope.

Blancett CD, Fetterer DP, Koistinen KA, Morazzani EM, Monninger MK, Piper AE, Kuehl KA, Kearney BJ, Norris SL, Rossi CA, Glass PJ, Sun MG.

J Virol Methods. 2017 Oct;248:136-144. doi: 10.1016/j.jviromet.2017.06.014. Epub 2017 Jun 29.

19.

Draft Genome Sequences of Eight Crimean-Congo Hemorrhagic Fever Virus Strains.

Koehler JW, Delp KL, Kearney BJ, Conrad TA, Schoepp RJ, Garrison AR, Altamura LA, Rossi CA, Minogue TD.

Genome Announc. 2017 Jun 8;5(23). pii: e00240-17. doi: 10.1128/genomeA.00240-17.

20.

Predicting Perioperative Transfusion in Elective Hip and Knee Arthroplasty: A Validated Predictive Model.

To J, Sinha R, Kim SW, Robinson K, Kearney B, Howie D, To LB.

Anesthesiology. 2017 Aug;127(2):317-325. doi: 10.1097/ALN.0000000000001709.

PMID:
28557816
21.

Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects.

Mogalian E, German P, Kearney BP, Yang CY, Brainard D, Link J, McNally J, Han L, Ling J, Mathias A.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02084-16. doi: 10.1128/AAC.02084-16. Print 2017 May.

22.

Corning HYPERFlask® for viral amplification and production of diagnostic reagents.

Kearney BJ, Voorhees MA, Williams PL, Olschner SP, Rossi CA, Schoepp RJ.

J Virol Methods. 2017 Apr;242:9-13. doi: 10.1016/j.jviromet.2016.12.011. Epub 2016 Dec 21.

PMID:
28012899
23.

Detection of Lyme disease and anaplasmosis pathogens via PCR in Pennsylvania deer ked.

Buss M, Case L, Kearney B, Coleman C, Henning JD.

J Vector Ecol. 2016 Dec;41(2):292-294. doi: 10.1111/jvec.12225.

24.

Pharmacokinetics, Pharmacodynamics, and Safety of Entospletinib, a Novel pSYK Inhibitor, Following Single and Multiple Oral Dosing in Healthy Volunteers.

Ramanathan S, Di Paolo JA, Jin F, Shao L, Sharma S, Robeson M, Kearney BP.

Clin Drug Investig. 2017 Feb;37(2):195-205. doi: 10.1007/s40261-016-0476-x.

25.

Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C.

German P, Mathias A, Brainard D, Kearney BP.

Clin Pharmacokinet. 2016 Nov;55(11):1337-1351. Review.

PMID:
27193156
26.

Reduced evolutionary rate in reemerged Ebola virus transmission chains.

Blackley DJ, Wiley MR, Ladner JT, Fallah M, Lo T, Gilbert ML, Gregory C, D'ambrozio J, Coulter S, Mate S, Balogun Z, Kugelman J, Nwachukwu W, Prieto K, Yeiah A, Amegashie F, Kearney B, Wisniewski M, Saindon J, Schroth G, Fakoli L, Diclaro JW 2nd, Kuhn JH, Hensley LE, Jahrling PB, Ströher U, Nichol ST, Massaquoi M, Kateh F, Clement P, Gasasira A, Bolay F, Monroe SS, Rambaut A, Sanchez-Lockhart M, Scott Laney A, Nyenswah T, Christie A, Palacios G.

Sci Adv. 2016 Apr 29;2(4):e1600378. doi: 10.1126/sciadv.1600378. eCollection 2016 Apr.

27.

Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment.

Custodio JM, Fordyce M, Garner W, Vimal M, Ling KH, Kearney BP, Ramanathan S.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5135-40. doi: 10.1128/AAC.00005-16. Print 2016 Sep.

28.

Short- and long-term consequences of developmental saline stress: impacts on anuran respiration and behaviour.

Kearney BD, Byrne PG, Reina RD.

R Soc Open Sci. 2016 Feb 24;3(2):150640. doi: 10.1098/rsos.150640. eCollection 2016 Feb.

29.

Pharmacokinetics of Co-Formulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate After Switch From Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Healthy Subjects.

Ramanathan S, Custodio JM, Wei X, Wang H, Fordyce M, Dave A, Ling KH, Szwarcberg J, Kearney BP.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):281-8. doi: 10.1097/QAI.0000000000000959.

PMID:
26885802
30.

Are manic symptoms that 'dip' into depression the essence of mixed features?

Malhi GS, Fritz K, Allwang C, Burston N, Cocks C, Devlin J, Harper M, Hoadley B, Kearney B, Klug P, Meagher L, Rowe M, Samir H, Way R, Wilson C, Lyndon W.

J Affect Disord. 2016 Mar 1;192:104-8. doi: 10.1016/j.jad.2015.12.009. Epub 2015 Dec 18.

PMID:
26717522
31.

Anaemia in elective orthopaedic surgery - Royal Adelaide Hospital, Australia.

Kearney B, To J, Southam K, Howie D, To B.

Intern Med J. 2016 Jan;46(1):96-101. doi: 10.1111/imj.12945.

PMID:
26524217
32.

Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug-Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir.

Mogalian E, German P, Kearney BP, Yang CY, Brainard D, McNally J, Moorehead L, Mathias A.

Clin Pharmacokinet. 2016 May;55(5):605-13. doi: 10.1007/s40262-015-0334-7.

PMID:
26519191
33.

Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib.

Ramanathan S, Jin F, Sharma S, Kearney BP.

Clin Pharmacokinet. 2016 Jan;55(1):33-45. doi: 10.1007/s40262-015-0304-0. Review.

PMID:
26242379
34.

Agitation for recognition by DSM-5 mixed features specifier signals fatigue?

Malhi GS, Fritz K, Allwang C, Burston N, Cocks C, Harper M, Kearney B, Klug P, Meagher L, Mimnagh J, Purayil S, Rowe M, Samir H, Way R, Wilson C, Lyndon W.

Aust N Z J Psychiatry. 2015 Jun;49(6):499-501. doi: 10.1177/0004867415585858. Epub 2015 Apr 30. No abstract available.

PMID:
25931574
35.

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir.

Kirby BJ, Symonds WT, Kearney BP, Mathias AA.

Clin Pharmacokinet. 2015 Jul;54(7):677-90. doi: 10.1007/s40262-015-0261-7. Review.

PMID:
25822283
36.

Evaluation of ViroCyt® Virus Counter for rapid filovirus quantitation.

Rossi CA, Kearney BJ, Olschner SP, Williams PL, Robinson CG, Heinrich ML, Zovanyi AM, Ingram MF, Norwood DA, Schoepp RJ.

Viruses. 2015 Feb 20;7(3):857-72. doi: 10.3390/v7030857.

37.

Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD.

Fetics SK, Guterres H, Kearney BM, Buhrman G, Ma B, Nussinov R, Mattos C.

Structure. 2015 Mar 3;23(3):505-516. doi: 10.1016/j.str.2014.12.017. Epub 2015 Feb 12.

38.
39.

Anuran larval developmental plasticity and survival in response to variable salinity of ecologically relevant timing and magnitude.

Kearney BD, Pell RJ, Byrne PG, Reina RD.

J Exp Zool A Ecol Genet Physiol. 2014 Dec;321(10):541-9. doi: 10.1002/jez.1887. Epub 2014 Nov 3.

PMID:
25366570
40.

Inadequate evaluation and management of threats in Australia's Marine Parks, including the Great Barrier Reef, misdirect Marine conservation.

Kearney B, Farebrother G.

Adv Mar Biol. 2014;69:253-88. doi: 10.1016/B978-0-12-800214-8.00007-4.

PMID:
25358302
41.

Near-atomic resolution reconstructions using a mid-range electron microscope operated at 200 kV.

Campbell MG, Kearney BM, Cheng A, Potter CS, Johnson JE, Carragher B, Veesler D.

J Struct Biol. 2014 Nov;188(2):183-7. Epub 2014 Sep 30.

42.

Assembly and maturation of a T = 4 quasi-equivalent virus is guided by electrostatic and mechanical forces.

Kearney BM, Johnson JE.

Viruses. 2014 Aug 22;6(8):3348-62. doi: 10.3390/v6083348. Review.

43.

Repair of horizontal meniscus tears: a systematic review.

Kurzweil PR, Lynch NM, Coleman S, Kearney B.

Arthroscopy. 2014 Nov;30(11):1513-9. doi: 10.1016/j.arthro.2014.05.038. Epub 2014 Aug 6. Review.

PMID:
25108905
44.

Dynamic and geometric analyses of Nudaurelia capensis ω virus maturation reveal the energy landscape of particle transitions.

Tang J, Kearney BM, Wang Q, Doerschuk PC, Baker TS, Johnson JE.

J Mol Recognit. 2014 Apr;27(4):230-7. doi: 10.1002/jmr.2354.

45.

Pharmacokinetics and safety of boosted elvitegravir in subjects with hepatic impairment.

Custodio JM, Rhee M, Shen G, Ling KH, Kearney BP, Ramanathan S.

Antimicrob Agents Chemother. 2014 May;58(5):2564-9. doi: 10.1128/AAC.02180-13. Epub 2014 Feb 18.

46.

Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults.

Markowitz M, Zolopa A, Squires K, Ruane P, Coakley D, Kearney B, Zhong L, Wulfsohn M, Miller MD, Lee WA.

J Antimicrob Chemother. 2014 May;69(5):1362-9. doi: 10.1093/jac/dkt532. Epub 2014 Feb 6.

PMID:
24508897
47.

Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatin.

Custodio JM, Wang H, Hao J, Lepist EI, Ray AS, Andrews J, Ling KH, Cheng A, Kearney BP, Ramanathan S.

J Clin Pharmacol. 2014 Jun;54(6):649-56. doi: 10.1002/jcph.256. Epub 2014 Jan 17.

PMID:
24375014
48.

DRoP: a water analysis program identifies Ras-GTP-specific pathway of communication between membrane-interacting regions and the active site.

Kearney BM, Johnson CW, Roberts DM, Swartz P, Mattos C.

J Mol Biol. 2014 Feb 6;426(3):611-29. doi: 10.1016/j.jmb.2013.10.036. Epub 2013 Nov 2.

PMID:
24189050
49.

Effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, an antiretroviral single-tablet regimen for the treatment of HIV infection.

Custodio JM, Yin X, Hepner M, Ling KH, Cheng A, Kearney BP, Ramanathan S.

J Clin Pharmacol. 2014 Apr;54(4):378-85. doi: 10.1002/jcph.210. Epub 2013 Nov 16.

PMID:
24142299
50.

Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenance.

Bruce RD, Winkle P, Custodio JM, Wei X, Rhee MS, Kearney BP, Ramanathan S, Friedland GH.

Antimicrob Agents Chemother. 2013 Dec;57(12):6154-7. doi: 10.1128/AAC.01229-13. Epub 2013 Sep 30.

Supplemental Content

Loading ...
Support Center